|NIAMS Names Dr. Robert Carter as Deputy
Robert H. Carter, M.D., former director of the Division of Clinical
Immunology and Rheumatology at the University of Alabama at Birmingham
(UAB), has been selected as deputy director of the National Institute
of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), a part
of the National Institutes of Health (NIH). Dr. Carter will be
assuming his official responsibilities as of October 1, 2008.
As deputy director, Dr. Carter will assist NIAMS Director Stephen
I. Katz, M.D., Ph.D., in providing strong and visionary leadership
to the NIAMS, an organization dedicated to a national innovative
research program in diseases of bones, muscles, joints, and skin.
In addition, he will contribute to the NIAMSí pursuit of cutting-edge
research on a broad spectrum of investigations, from basic science
to clinical studies, with translational research as a particular
area of interest.
|Dr. Robert Carter
"I am delighted to welcome Dr. Carter to the NIAMS," said
Dr. Katz. "His stellar credentials as a scientist and his
broad experience in NIH extramural activities will contribute to
NIAMSí long history of excellence in biomedical research."
Dr. Carter is professor of medicine at UAB and has most recently
served as director of the Division of Clinical Immunology and Rheumatology.
He is the principal investigator (PI) of the NIAMS-supported UAB
Rheumatic Disease Core Center, and the PI of an Autoimmunity Center
of Excellence supported by the NIHís National Institute of Allergy
and Infectious Diseases (NIAID). He also serves as staff physician
at the Birmingham Veterans Affairs Medical Center.
Dr. Carter is board certified in rheumatology and internal medicine
and has an established record of exemplary career achievements
in the fields of rheumatology and immunology. Specifically, Dr.
Carter and his colleagues have been leaders in contributing to
the understanding of molecular regulation of B lymphocyte activation
to identify targets for therapeutic control of autoantibody production.
A major focus of his work has been on signal transduction by the
B cell surface molecule CD19. Recently, Dr. Carter and his group
have expanded their focus to include target identification in human
lupus and the study of B cells in the immune response of healthy
individuals. His work is funded by grants from the NIAMS, the NIAID,
the U.S. Department of Veterans Affairs (VA), and private industry.
Dr. Carter has proven his scientific leadership through an extensive
record of publications and editorial activities; committee and
training commitments; teaching and mentoring dedication; consultations
and speaking engagements; and awards and honors. He holds memberships
with the Association of American Physicians, the American College
of Rheumatology (ACR), the American College of Physicians, the
American Association of Immunologists, and the American Association
for the Advancement of Science. He serves on the Committee for
Research of the ACR, the Medical and Scientific Advisory Committee
for the Lupus Foundation of America, Inc., and on the program committee
for the 2008 annual meeting of the Henry Kunkel Society. He has
served on numerous study sections and served as a consultant to
the NIH Recombinant DNA Advisory Committee. He is also a VA Merit
Dr. Carter received his bachelorís degree from Williams College
in Williamstown, Mass., in 1978, Magna cum Laude, in biology. He
received his medical degree from Harvard Medical School in 1982.
He trained in internal medicine at the University of Virginia Health
Sciences Center in Charlottesville. In addition, he was a fellow
in rheumatology and immunology at Brigham and Womenís Hospital
in Boston, and in molecular and clinical rheumatology at the Johns
Hopkins University School of Medicine in Baltimore.
The mission of the National Institute of Arthritis and Musculoskeletal
and Skin Diseases (NIAMS), a part of the Department of Health and
Human Services' National Institutes of Health (NIH), is to support
research into the causes, treatment, and prevention of arthritis
and musculoskeletal and skin diseases; the training of basic and
clinical scientists to carry out this research; and the dissemination
of information on research progress in these diseases. For more
information about NIAMS, call the information clearinghouse at
301-495-4484 or 877-22-NIAMS (free call) or visit the NIAMS Web
site at http://www.niams.nih.gov.
The National Institutes of Health (NIH) — The Nation's
Medical Research Agency — includes 27 Institutes and Centers
and is a component of the U.S. Department of Health and Human Services.
It is the primary federal agency for conducting and supporting basic,
clinical and translational medical research, and it investigates
the causes, treatments, and cures for both common and rare diseases.
For more information about NIH and its programs, visit www.nih.gov.
Note: At the request of the institute, an image of Dr. Carter was
added to this release on 8/14/2008